HOME >> BIOLOGY >> NEWS
Applied Biosystems and Immune Tolerance Network announce immunology research agreement

Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, and the Immune Tolerance Network (ITN) announced a multi-year agreement to study genes expressed in clinical samples that are believed to be related to immune response modulation in organ transplantation, autoimmune disease, and allergy and asthma. Financial terms of the agreement were not disclosed.

This agreement is a follow-on to a previous program in which the ITN and Applied Biosystems developed a set of functionally validated gene expression assays based on genes predicted to be involved in the modulation of the immune response. In the latest agreement, Applied Biosystems, through its Knowledge Business Genomics Services group, is expected to analyze the set of approximately 1,000 assays in specimens taken from ITN sponsored clinical trials. Under the agreement, ITN will make public the list of genes and clinical trial protocols and Applied Biosystems intends to provide commercial access to the complete assay set by this Spring through its Assays-on-DemandTM Gene Expression Product offering. Approximately two-thirds of the gene expression assays from the ITN set are already available through the enhanced Applied Biosystems e-commerce web site.

ITN intends to use the gene expression data derived from these studies to assess relative expression levels of genes between normal controls and patients, and in single patients at various time points throughout the clinical trials. The data is expected to be used to track parameters such as disease onset, disease progression and patient responses to therapeutics. It is hoped that these studies will result in a better understanding of the mechanisms that relate to the induction, loss and/or maintenance of tolerance and identify new genetic markers for tolerance in humans. Ultimately, this marriage of clinical and genetic sciences in the tolerance arena is designed to improve therapeutic options in organ transplantatio
'"/>


7-Jan-2003


Page: 1 2 3 4

Related biology news :

1. Applied Mathematical Models in Human Physiology
2. Dana-Farber launches Center for Applied Cancer Science
3. Applied Biosystems announces $250,000 grant program for SNP genotyping studies
4. Applied Biosystems announces enhancements to Celera Discovery System and new subscription model
5. Applied Biosystems announces SNPlex ultra high throughput genotyping system
6. Applied Biosystems introduces new chemistries to increase DNA sequencing productivity
7. Applied Biosystems launches Assays-on-Demand SNP genotyping and gene expression products
8. Applied Biosystems introduces new system for protein and metabolite analysis
9. Hutch Researcher Wins Nobel Prize Of Applied Research
10. Biosphere Lessons Can Be Applied To Space, Former Crew Co-Captain Says
11. Immune systems attack dogs kept on genetic leash

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/5/2020)... ... June 04, 2020 , ... Greffex, a pioneering vaccine and gene therapy company ... “Neil understands the need for a global perspective to make an impact in a ... Bush will serve as an independent, director of the company. , “The Greffex board ...
(Date:5/28/2020)... ... May 28, 2020 , ... DuPont ... liquefaction: AMYLEX® 6T. The innovative enzyme enables numerous business gains for breweries ... locally-sourced raw materials, improve productivity, maximize yield, ensure consistent quality and ultimately ...
(Date:5/21/2020)... ... May 19, 2020 , ... ... software-as-a-service (SaaS) provider of operations management solutions, today introduced BioMed to their ... a cloud-based platform for connecting the people and systems around biomedical engineering ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... ... May 19, 2020 , ... Experienced periodontist in Eden Prairie, MN, ... and bone grafting through PIEZOSURGERY® technology. PIEZOSURGERY uses ultrasonic vibrations to gently ... prepare a patient for dental implants, especially when the implants need to be placed ...
(Date:5/21/2020)... ... May 20, 2020 , ... ... Prakash, who will serve as the company’s executive vice president of product engineering ... Exo is disrupting the medical imaging space, bringing more than 24 years of ...
(Date:5/15/2020)... ... May 14, 2020 , ... Children with defective ... surgeries before becoming adults. The reason: there are no heart valve prosthetics ... need, the Department of Defense has awarded Draper, Boston Children’s Hospital and Seattle ...
(Date:5/15/2020)... ... May 15, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Executive Chairman. Mr. Ganz will continue to lead Sentien’s Board of Directors, a ... with CEO Brian Miller and Sentien’s management team. , Mr. Ganz has ...
Breaking Biology Technology:
Cached News: